Text Message Reminders for Hearing Healthcare

Sponsor
Stanford University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05438225
Collaborator
(none)
40
1
2
12
3.3

Study Details

Study Description

Brief Summary

Many individuals with hearing loss do not receive adequate hearing healthcare. Given their close and long-term relationships with patients, primary care providers (PCPs) could play a vital role in improving access to hearing healthcare. Unfortunately, hearing loss is often underdiagnosed in primary care settings, because hearing screening is not a routine part of primary care visits, and the responsibility often falls on the patient or family to recognize and address the issue. The investigators propose to pilot test the use of text message reminders to encourage elderly patients to discuss hearing assessment with there PCPs. The study objectives are to: 1) design an automated text-messaging reminder system; 2) assess the feasibility of deploying the intervention in a clinical trial setting; and 3) evaluate whether the intervention increases willingness to seek hearing healthcare.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Automated text message reminder
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Care Provider, Outcomes Assessor)
Primary Purpose:
Health Services Research
Official Title:
Automated Text Message Reminders to Promote Hearing Healthcare Access - Pilot Study
Anticipated Study Start Date :
Aug 1, 2022
Anticipated Primary Completion Date :
Aug 1, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Automated Text Message Reminder

Participants will receive automated reminder text instructing them to discuss hearing issues with their PCPs, and to request a referral to audiology or otolaryngology if they have hearing loss.

Behavioral: Automated text message reminder
Participants in the intervention group will receive monthly automated reminder text instructing them to discuss hearing issues with their PCPs, and to request a referral to audiology or otolaryngology if they have hearing loss.

No Intervention: Control Group

Outcome Measures

Primary Outcome Measures

  1. Likelihood of patient-physician discussion of hearing loss or hearing assessment [3 months after enrollment]

    Participant-reported rating of the likelihood of discussing hearing assessment with their PCP in the next 6 months. Likelihood will be assessed on an 11-point visual analogue scale (VAS). Score range: 0 to 10 (0 = not likely, 10 = very likely). Participants who have already discussed hearing assessment with their PCP will be assigned a score of 10.

Secondary Outcome Measures

  1. Likelihood of obtaining audiogram [3 months after enrollment]

    Participant-reported rating of the likelihood of obtaining an audiogram in the next 6 months. Likelihood will be assessed on an 11-point visual analogue scale (VAS). Score range: 0 to 10 (0 = not likely, 10 = very likely). Participants who have already undergone audiometric testing will be assigned a score of 10.

  2. Likelihood of obtaining hearing aids [3 months after enrollment]

    Participant-reported rating of the likelihood of obtaining hearing aids if an audiogram showed significant hearing loss. Likelihood will be assessed on an 11-point visual analogue scale (VAS). Score range: 0 to 10 (0 = not likely, 10 = very likely). Participants who have already obtained hearing aids will be assigned a score of 10.

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • English-speaking adult patients aged 65 and older

  • Have not audiometric testing within the past 5 years

  • Has had at least one prior visit encounter with a Stanford primary care provider the past 1 year

  • Has a cell phone with a valid phone number

Exclusion Criteria:
  • History of childhood hearing loss

  • Hearing aid users

  • Limited English proficiency

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stanford University Stanford California United States 94305

Sponsors and Collaborators

  • Stanford University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Uchechukwu Megwalu, Associate Professor of Otolaryngology - Head & Neck Surgery, Stanford University
ClinicalTrials.gov Identifier:
NCT05438225
Other Study ID Numbers:
  • IRB-66347
First Posted:
Jun 29, 2022
Last Update Posted:
Jul 6, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Uchechukwu Megwalu, Associate Professor of Otolaryngology - Head & Neck Surgery, Stanford University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 6, 2022